We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.52%
2 Healthcare 9.35%
3 Financials 9.23%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOS
1826
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$2.62M ﹤0.01%
158,123
+616
+0.4% +$10.3K
EVBG
1827
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.62M ﹤0.01%
88,433
-3,444
-4% -$106K
ESAB icon
1828
ESAB
ESAB
$5.29B
$2.61M ﹤0.01%
55,637
-2,050
-4% -$85.8K
CHGG icon
1829
Chegg
CHGG
$89.3M
$2.61M ﹤0.01%
103,213
+21,453
+26% +$545K
BNS icon
1830
Scotiabank
BNS
$110B
$2.61M ﹤0.01%
53,246
-751
-1% -$37K
CROX icon
1831
Crocs
CROX
$6.36B
$2.61M ﹤0.01%
24,037
+3,684
+18% +$326K
QQH icon
1832
HCM Defender 100 Index ETF
QQH
$772M
$2.59M ﹤0.01%
76,178
+2,189
+3% +$77.2K
HQH
1833
abrdn Healthcare Investors
HQH
$1.34B
$2.59M ﹤0.01%
143,701
+8,173
+6% +$151K
KBWP icon
1834
Invesco KBW Property & Casualty Insurance ETF
KBWP
$267M
$2.58M ﹤0.01%
29,998
-2,493
-8% -$208K
PRGS icon
1835
Progress Software
PRGS
$1.79B
$2.58M ﹤0.01%
51,121
+856
+2% +$42.7K
ECHO
1836
EchoStar
ECHO
$26.6B
$2.58M ﹤0.01%
154,613
-53,504
-26% -$927K
ICF icon
1837
iShares Select U.S. REIT ETF
ICF
$2.11B
$2.56M ﹤0.01%
46,753
-1,470
-3% -$80.4K
PGNY icon
1838
Progyny
PGNY
$1.99B
$2.56M ﹤0.01%
82,223
+12,862
+19% +$465K
OSH
1839
DELISTED
Oak Street Health, Inc.
OSH
$2.56M ﹤0.01%
119,051
+3,592
+3% +$75.1K
RLY icon
1840
State Street Multi-Asset Real Return ETF
RLY
$1.31B
$2.56M ﹤0.01%
92,893
+7,652
+9% +$214K
BRKR icon
1841
Bruker
BRKR
$8.83B
$2.55M ﹤0.01%
37,350
+2,021
+6% +$128K
NMIH icon
1842
NMI Holdings
NMIH
$3.38B
$2.54M ﹤0.01%
121,696
+45,949
+61% +$962K
SLM icon
1843
SLM Corp
SLM
$5.26B
$2.54M ﹤0.01%
152,873
-5,871
-4% -$96.2K
U icon
1844
Unity
U
$20.2B
$2.54M ﹤0.01%
88,697
-21,976
-20% -$688K
IBP icon
1845
Installed Building Products
IBP
$6.46B
$2.53M ﹤0.01%
29,510
+5,156
+21% +$435K
PHO icon
1846
Invesco Water Resources ETF
PHO
$2.06B
$2.52M ﹤0.01%
48,949
+2,239
+5% +$113K
SCHA icon
1847
Schwab U.S Small- Cap ETF
SCHA
$23.5B
$2.52M ﹤0.01%
124,480
+14,574
+13% +$299K
FNOV icon
1848
FT Vest US Equity Buffer ETF November
FNOV
$1.24B
$2.52M ﹤0.01%
+70,811
New +$2.49M
RXO icon
1849
RXO
RXO
$3.85B
$2.51M ﹤0.01%
+146,125
New +$2.59M
ITGR icon
1850
Integer Holdings
ITGR
$4.25B
$2.51M ﹤0.01%
36,662
-3,886
-10% -$254K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.